149 related articles for article (PubMed ID: 31948053)
1. The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype.
Mayer P; Linnebacher A; Glennemeier-Marke H; Marnet N; Bergmann F; Hackert T; Klauss M; Poth T; Gaida MM
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948053
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
[TBL] [Abstract][Full Text] [Related]
3. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
4. Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging.
Mayer P; Dinkic C; Jesenofsky R; Klauss M; Schirmacher P; Dapunt U; Hackert T; Uhle F; Hänsch GM; Gaida MM
Theranostics; 2018; 8(1):13-30. PubMed ID: 29290790
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer.
Linnebacher A; Mayer P; Marnet N; Bergmann F; Herpel E; Revia S; Yin L; Liu L; Hackert T; Giese T; Herr I; Gaida MM
Cells; 2019 Sep; 8(9):. PubMed ID: 31540511
[TBL] [Abstract][Full Text] [Related]
6. IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer.
He W; Wu J; Shi J; Huo YM; Dai W; Geng J; Lu P; Yang MW; Fang Y; Wang W; Zhang ZG; Habtezion A; Sun YW; Xue J
Cancer Res; 2018 Jun; 78(12):3293-3305. PubMed ID: 29572224
[TBL] [Abstract][Full Text] [Related]
7. Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis.
Noda Y; Tomita H; Ishihara T; Tsuboi Y; Kawai N; Kawaguchi M; Kaga T; Hyodo F; Hara A; Kambadakone AR; Matsuo M
BMC Med Imaging; 2022 Feb; 22(1):23. PubMed ID: 35135492
[TBL] [Abstract][Full Text] [Related]
8. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MR imaging in pancreatic ductal adenocarcinoma: prediction of next-generation sequencing-based tumor cellularity and prognosis after surgical resection.
Jeon SK; Jang JY; Kwon W; Kim H; Han Y; Kim D; Park D; Kim JH
Abdom Radiol (NY); 2021 Oct; 46(10):4787-4799. PubMed ID: 34143259
[TBL] [Abstract][Full Text] [Related]
10. Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer.
Heid I; Steiger K; Trajkovic-Arsic M; Settles M; Eßwein MR; Erkan M; Kleeff J; Jäger C; Friess H; Haller B; Steingötter A; Schmid RM; Schwaiger M; Rummeny EJ; Esposito I; Siveke JT; Braren RF
Clin Cancer Res; 2017 Mar; 23(6):1461-1470. PubMed ID: 27663591
[No Abstract] [Full Text] [Related]
11. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
[TBL] [Abstract][Full Text] [Related]
12. DWI of Pancreatic Ductal Adenocarcinoma: A Pilot Study to Estimate the Correlation With Metastatic Disease Potential and Overall Survival.
Garces-Descovich A; Morrison TC; Beker K; Jaramillo-Cardoso A; Moser AJ; Mortele KJ
AJR Am J Roentgenol; 2019 Feb; 212(2):323-331. PubMed ID: 30667305
[TBL] [Abstract][Full Text] [Related]
13. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma.
Rong D; Mao Y; Hu W; Xu S; Wang J; He H; Li S; Zhang R
Eur Radiol; 2018 Jul; 28(7):2781-2789. PubMed ID: 29404768
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
16. Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer.
Tang ES; Newell PH; Wolf RF; Hansen PD; Cottam B; Ballesteros-Merino C; Gough MJ
JAMA Surg; 2018 Nov; 153(11):1055-1057. PubMed ID: 30090929
[TBL] [Abstract][Full Text] [Related]
17. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
18. Influence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: A pilot study.
Swartz JE; Driessen JP; van Kempen PMW; de Bree R; Janssen LM; Pameijer FA; Terhaard CHJ; Philippens MEP; Willems S
Oral Oncol; 2018 Feb; 77():9-15. PubMed ID: 29362130
[TBL] [Abstract][Full Text] [Related]
19. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B
Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
